Bio-Rad launches StarBright UltraViolet700 dye for spectral flow
Bio-Rad Laboratories has expanded its StarBright fluorescent dye portfolio with the introduction of StarBright UltraViolet700 (SBUV700), specifically engineered for spectral flow cytometry applications in immunology research. The new dye represents the first in a planned series rollout over the coming months, targeting enhanced panel design capabilities for clinical laboratories and research institutions.
Enhanced spectral properties drive multiplexing capabilities
The StarBright UltraViolet700 dye demonstrates unique spectral characteristics with maximal emission peaks optimised for multiplexing panels. Conjugated to highly validated immunology antibodies against 46 markers commonly found in immunological samples, including 13 newly available markers, the dye exhibits narrow excitation and emission profiles designed to minimise spectral spreading whilst maximising resolution.
“We continue to expand our StarBright Dye range of fluorescent markers for flow cytometry, which now includes over 30 dyes,” said Hilary Mavor, Marketing Director, Life Science Group, Bio-Rad Laboratories. “The new range, beginning with launch of the new StarBright UltraViolet700 Dye, provides our customers with greater options when designing spectral flow cytometry panels, allowing for novel dye combinations and the creation of larger multicolour panels of increased complexity.”
Broad instrument compatibility supports laboratory integration
The StarBright dye series maintains compatibility with Bio-Rad’s ZE5 Cell Analyzer alongside most conventional flow cytometers, cell sorters, and spectral instruments. This cross-platform functionality enables seamless integration into existing laboratory workflows without requiring substantial instrument modifications.
Technical specifications enable advanced panel design
Bio-Rad’s StarBright Dyes deliver exceptional brightness characteristics whilst maintaining narrow spectral profiles, providing researchers with expanded options for complex panel development. The dyes can be incorporated into both new experimental protocols and existing assays, supporting flexible laboratory implementation strategies.
The Hercules, California-based company operates a global network serving universities, research institutions, hospitals, and biopharmaceutical companies. With approximately 7,700 employees and $2.6 billion in revenues in 2024, Bio-Rad continues advancing life science research and clinical diagnostics capabilities.
- For more information, visit: bio-rad-antibodies.com/StarBrightDyes
